Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Avadel Pharmaceuticals (AVDL) Stock Price & Analysis
516 Followers
AVDL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.12 - $15.82
Previous Close$14.84
Volume339.21K
Average Volume (3M)935.85K
Market Cap
$935.51M
Enterprise Value$949.75M
Total Cash (Recent Filing)$100.92M
Total Debt (Recent Filing)$115.16M
Price to Earnings (P/E)-6.4
Beta0.98
Next Earnings
Aug 08, 2023EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.33
Shares Outstanding61,780,000
10 Day Avg. Volume697,757
30 Day Avg. Volume935,848
Standard Deviation0.28
R-Squared0.08
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-15.84
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.19K
Enterprise Value/Gross Profit-283.93
Enterprise Value/Ebitda-10.32
Forecast
1Y Price Target
$17.44Price Target Upside19.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Avadel Pharmaceuticals News
Pre-EarningsAVDL Upcoming Earnings Report: What to Expect?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AVDL FAQ
What was Avadel Pharmaceuticals’s price range in the past 12 months?
Avadel Pharmaceuticals lowest stock price was $2.12 and its highest was $15.82 in the past 12 months.
What is Avadel Pharmaceuticals’s market cap?
Currently, no data Available
When is Avadel Pharmaceuticals’s upcoming earnings report date?
Avadel Pharmaceuticals’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
How were Avadel Pharmaceuticals’s earnings last quarter?
Avadel Pharmaceuticals released its earnings results on May 04, 2023. The company reported -$0.48 earnings per share for the quarter, missing the consensus estimate of -$0.367 by -$0.113.
Is Avadel Pharmaceuticals overvalued?
According to Wall Street analysts Avadel Pharmaceuticals’s price is currently Undervalued.
Does Avadel Pharmaceuticals pay dividends?
Avadel Pharmaceuticals does not currently pay dividends.
What is Avadel Pharmaceuticals’s EPS estimate?
Avadel Pharmaceuticals’s EPS estimate is -$0.36.
How many shares outstanding does Avadel Pharmaceuticals have?
Avadel Pharmaceuticals has 76,768,394 shares outstanding.
What happened to Avadel Pharmaceuticals’s price movement after its last earnings report?
Avadel Pharmaceuticals reported an EPS of -$0.48 in its last earnings report, missing expectations of -$0.367. Following the earnings report the stock price went up 4.982%.
Which hedge fund is a major shareholder of Avadel Pharmaceuticals?
Among the largest hedge funds holding Avadel Pharmaceuticals’s share is Woodline Partners LP. It holds Avadel Pharmaceuticals’s shares valued at 17M.
---
Avadel Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.44 (19.21% Upside)
$17.44 (19.21% Upside)
Blogger Sentiment
Bullish
AVDL Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $218.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 4.5%
Last 30 Days ▲ 4.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
518.33%
12-Months-Change
Fundamentals
Return on Equity
-1662.06%
Trailing 12-Months
Asset Growth
-36.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Avadel Pharmaceuticals
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
---
Top 5 ETFs holding AVDL
iShares NASDAQ US Biotechnology UCITS ETF
$426.61K
Fidelity Nasdaq Composite Index ETF
$414.36K
Invesco Nasdaq Biotechnology ETF
$16.82K
Up to five ETFs with an Outperform Smart Score that hold AVDL. The ETFs are listed according to market value of AVDL within the ETF
---
---